How retatrutide compares to other GLP-1 options Retatrutide does not exist in isolation
Common adverse effects reported by participants who took the highest dose of retatrutide in the TRIUMPH-1 trial included nausea (42.4% of participants), diarrhoea (32.0% of participants), constipation (26.1% of participants) and vomiting (25.3% of participants)
Efficacy: Tirzepatide has shown higher overall weight loss percentages, making it a potentially stronger option for those with higher weight loss goals
Smanjenje food noise efekta Jedan od najzanimljivijih fenomena koji pacijenti opisuju jeste tzv
It mimics GLP-1, a hormone found within the intestines
Wang L, Yang Z, Fu J, Yin H, Xiong K, et al